DiscoverPitchfork Economics with Nick HanauerVaccine development needs new incentives (with Tahir Amin)
Vaccine development needs new incentives (with Tahir Amin)

Vaccine development needs new incentives (with Tahir Amin)

Update: 2020-06-161
Share

Description

COVID-19 has exposed the limits of the pharmaceutical market model. This week, patent law expert Tahir Amin joins the show to explain why vaccine development needs new incentives.


Tahir Amin is an attorney dedicated to reshaping patent law to better serve the public. He is the Co-Founder and Co-ED of the Initiative for Medicines, Access, and Knowledge (I-MAK), a global nonprofit organization of attorneys, scientists, and health experts working on systemic changes to intellectual property and the political economy of pharmaceutical innovation. 


Twitter: @realtahiramin


Further reading: 

Covid-19 has exposed the limits of the pharmaceutical market model: https://www.statnews.com/2020/05/19/covid-19-exposed-limits-drug-development-model/


No vaccine in sight: https://newrepublic.com/article/157594/no-coronavirus-vaccine-big-pharma-drug-patent-system


Democrats punt on drug-pricing overhaul in virus relief measure: https://news.bloomberglaw.com/health-law-and-business/democrats-punt-on-drug-pricing-overhaul-in-virus-relief-measure


Website: http://pitchforkeconomics.com/

Twitter: @PitchforkEcon

Instagram: @pitchforkeconomics

Nick’s twitter: @NickHanauer

Comments (1)

ncooty

@19:15: It doesn't "beg the question;" it raises the question. To "beg the question" is to commit a logical fallacy in which one assumes the conclusion.

Jun 18th
Reply
Download from Google Play
Download from App Store
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Vaccine development needs new incentives (with Tahir Amin)

Vaccine development needs new incentives (with Tahir Amin)

Civic Ventures